Cargando…
Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis
BACKGROUND: Skin-restricted lupus is a chronic inflammatory disease associated with high rates of depression and anxiety disorders. Patients without psychiatric disorders can experience anxiety and depressive symptoms at a subclinical level, which could be risk factors for progression towards psychi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977055/ https://www.ncbi.nlm.nih.gov/pubmed/36857334 http://dx.doi.org/10.1371/journal.pone.0282079 |
_version_ | 1784899212358451200 |
---|---|
author | Rondepierre, Fabien Tauveron-Jalenques, Urbain Valette, Solène Mulliez, Aurélien D’Incan, Michel Lauron, Sophie Jalenques, Isabelle |
author_facet | Rondepierre, Fabien Tauveron-Jalenques, Urbain Valette, Solène Mulliez, Aurélien D’Incan, Michel Lauron, Sophie Jalenques, Isabelle |
author_sort | Rondepierre, Fabien |
collection | PubMed |
description | BACKGROUND: Skin-restricted lupus is a chronic inflammatory disease associated with high rates of depression and anxiety disorders. Patients without psychiatric disorders can experience anxiety and depressive symptoms at a subclinical level, which could be risk factors for progression towards psychiatric disorders. It was decided, therefore, to investigate the presence of specific symptoms in skin-restricted lupus patients without axis I psychiatric disorders and their impact on the occurrence of axis I psychiatric disorders during the study follow-up. METHODS: Longitudinal data of 38 patients and 76 matched controls without active axis I psychiatric disorders from the LuPsy cohort were used. Depressive, neurovegetative, psychic and somatic anxiety symptom scores were established from the Montgomery-Asberg Depression Rating Scale (MADRS) and the Hamilton Anxiety Rating scale (HAMA). RESULTS: None of the participants had any current active axis I psychiatric disorders but the patients had personality disorders more frequently and had received more past psychotropic treatments than the controls. They also had higher MADRS and HAMA scores than the controls, in particular neurovegetative, psychic anxiety and somatic symptoms scores. No dermatological factor tested was associated with these scores, whereas being a lupus patient was associated with higher neurovegetative and somatic symptoms scores, having a current personality disorder with higher depressive and neurovegetative scores and receiving more past psychotropic treatments with psychic anxiety and somatic symptoms scores. The occurrence of psychiatric disorders during the study follow-up was associated with an elevated psychic anxiety score at baseline and past psychotropic treatment but not with history of psychiatric disorder. LIMITATIONS: The LuPsy cohort included a large number of patients with axis I psychiatric disorders, the sample without axis I psychiatric disorders is therefore limited. CONCLUSIONS: We observed numerous psychiatric symptoms among the skin-restricted lupus patients. They should therefore receive special attention in the management of their subclinical symptoms before they progress towards full psychiatric disorders. |
format | Online Article Text |
id | pubmed-9977055 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-99770552023-03-02 Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis Rondepierre, Fabien Tauveron-Jalenques, Urbain Valette, Solène Mulliez, Aurélien D’Incan, Michel Lauron, Sophie Jalenques, Isabelle PLoS One Research Article BACKGROUND: Skin-restricted lupus is a chronic inflammatory disease associated with high rates of depression and anxiety disorders. Patients without psychiatric disorders can experience anxiety and depressive symptoms at a subclinical level, which could be risk factors for progression towards psychiatric disorders. It was decided, therefore, to investigate the presence of specific symptoms in skin-restricted lupus patients without axis I psychiatric disorders and their impact on the occurrence of axis I psychiatric disorders during the study follow-up. METHODS: Longitudinal data of 38 patients and 76 matched controls without active axis I psychiatric disorders from the LuPsy cohort were used. Depressive, neurovegetative, psychic and somatic anxiety symptom scores were established from the Montgomery-Asberg Depression Rating Scale (MADRS) and the Hamilton Anxiety Rating scale (HAMA). RESULTS: None of the participants had any current active axis I psychiatric disorders but the patients had personality disorders more frequently and had received more past psychotropic treatments than the controls. They also had higher MADRS and HAMA scores than the controls, in particular neurovegetative, psychic anxiety and somatic symptoms scores. No dermatological factor tested was associated with these scores, whereas being a lupus patient was associated with higher neurovegetative and somatic symptoms scores, having a current personality disorder with higher depressive and neurovegetative scores and receiving more past psychotropic treatments with psychic anxiety and somatic symptoms scores. The occurrence of psychiatric disorders during the study follow-up was associated with an elevated psychic anxiety score at baseline and past psychotropic treatment but not with history of psychiatric disorder. LIMITATIONS: The LuPsy cohort included a large number of patients with axis I psychiatric disorders, the sample without axis I psychiatric disorders is therefore limited. CONCLUSIONS: We observed numerous psychiatric symptoms among the skin-restricted lupus patients. They should therefore receive special attention in the management of their subclinical symptoms before they progress towards full psychiatric disorders. Public Library of Science 2023-03-01 /pmc/articles/PMC9977055/ /pubmed/36857334 http://dx.doi.org/10.1371/journal.pone.0282079 Text en © 2023 Rondepierre et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Rondepierre, Fabien Tauveron-Jalenques, Urbain Valette, Solène Mulliez, Aurélien D’Incan, Michel Lauron, Sophie Jalenques, Isabelle Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis |
title | Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis |
title_full | Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis |
title_fullStr | Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis |
title_full_unstemmed | Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis |
title_short | Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis |
title_sort | psychiatric symptomatology in skin-restricted lupus patients without axis i psychiatric disorders: a post-hoc analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977055/ https://www.ncbi.nlm.nih.gov/pubmed/36857334 http://dx.doi.org/10.1371/journal.pone.0282079 |
work_keys_str_mv | AT rondepierrefabien psychiatricsymptomatologyinskinrestrictedlupuspatientswithoutaxisipsychiatricdisordersaposthocanalysis AT tauveronjalenquesurbain psychiatricsymptomatologyinskinrestrictedlupuspatientswithoutaxisipsychiatricdisordersaposthocanalysis AT valettesolene psychiatricsymptomatologyinskinrestrictedlupuspatientswithoutaxisipsychiatricdisordersaposthocanalysis AT mulliezaurelien psychiatricsymptomatologyinskinrestrictedlupuspatientswithoutaxisipsychiatricdisordersaposthocanalysis AT dincanmichel psychiatricsymptomatologyinskinrestrictedlupuspatientswithoutaxisipsychiatricdisordersaposthocanalysis AT lauronsophie psychiatricsymptomatologyinskinrestrictedlupuspatientswithoutaxisipsychiatricdisordersaposthocanalysis AT jalenquesisabelle psychiatricsymptomatologyinskinrestrictedlupuspatientswithoutaxisipsychiatricdisordersaposthocanalysis |